Fagron NV 

$27.50
120
+$0.50+1.85% Monday 20:00

Statistics

Day High
27
Day Low
27
52W High
27.9
52W Low
23.5
Volume
2,500
Avg. Volume
6
Mkt Cap
2.02B
P/E Ratio
18.82
Dividend Yield
1.69%
Dividend
0.46

Upcoming

Dividends

1.69%Dividend Yield
May 26
$0.46
May 25
$0.40
May 24
$0.32
May 23
$0.27
May 22
$0.21
10Y Growth
N/A
5Y Growth
16.24%
3Y Growth
19.72%
1Y Growth
17.23%

Earnings

30JulExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0
0.18
0.36
0.55
Expected EPS
N/A
Actual EPS
N/A

Financials

9.56%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.12BRevenue
107.04MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ARSUF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Fagron N.V. is a specialized pharmaceutical compounding firm focused on delivering tailored medicinal solutions. The company caters to a diverse range of clients, including hospitals, pharmacies, clinics, and individual patients. Beyond providing direct services, Fagron N.V. actively drives innovation by developing cutting-edge concepts, delivery methods, and specific formulations for pharmaceutical compounding. Its extensive product line includes essential raw materials, specialized tools and equipment, semi-finished goods, various drug vehicles, and both sterile and non-sterile custom-prepared medications. Furthermore, the company supports professional development through the Fagron Academy, offering comprehensive education and training programs for medical prescribers and pharmacists. With a significant global presence, Fagron N.V. operates across Latin America, North America, Europe, the Middle East, and Africa. Founded in 1990 and headquartered in Nazareth, Belgium, the company underwent a name change in January 2015, rebranding from its former identity, Arseus N.V., to Fagron N.V.
Show more...
CEO
Rafael Padilla
Employees
4134
Country
Belgium
ISIN
BE0003874915
WKN
000A0M103

Listings

0 Comments

Share your thoughts

FAQ

What is Fagron NV stock price today?
The current price of ARSUF is $27.50 USD — it has increased by +1.85% in the past 24 hours. Watch Fagron NV stock price performance more closely on the chart.
What is Fagron NV stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Fagron NV stocks are traded under the ticker ARSUF.
What is Fagron NV market cap?
Today Fagron NV has the market capitalization of 2.02B
When is the next Fagron NV earnings date?
Fagron NV is going to release the next earnings report on February 18, 2027.
What is Fagron NV revenue for the last year?
Fagron NV revenue for the last year amounts to 1.12B USD.
What is Fagron NV net income for the last year?
ARSUF net income for the last year is 107.04M USD.
Does Fagron NV pay dividends?
Yes, ARSUF dividends are paid annual. The last dividend per share was 0.46 USD. As of today, Dividend Yield (FWD)% is 1.69%.
How many employees does Fagron NV have?
As of September 04, 2026, the company has 4,134 employees.
In which sector is Fagron NV located?
Fagron NV operates in the Health & Wellness sector.
When did Fagron NV complete a stock split?
Fagron NV has not had any recent stock splits.
Where is Fagron NV headquartered?
Fagron NV is headquartered in Nazareth, Belgium.